969 (Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual) 2 mg (base) / 0.5 mg (base))
Pill with imprint 969 is Orange, Round and has been identified as Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual) 2 mg (base) / 0.5 mg (base). It is supplied by Sun Pharmaceutical Industries Inc..
Buprenorphine/naloxone is used in the treatment of opiate dependence and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Buprenorphine/naloxone 2 mg (base) / 0.5 mg (base) is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).
Images for 969
Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual)
- Imprint:
- 969
- Strength:
- 2 mg (base) / 0.5 mg (base)
- Color:
- Orange
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Narcotic analgesic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 3 - Moderate abuse potential
- Labeler / Supplier:
- Sun Pharmaceutical Industries Inc.
- National Drug Code (NDC):
- 62756-0969
More about buprenorphine/naloxone
- Buprenorphine/naloxone Side Effects
- During Pregnancy
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 691 Reviews
- Drug class: narcotic analgesic combinations
Consumer resources
- Buprenorphine and naloxone oral/sublingual
- Buprenorphine and Naloxone Sublingual Tablets
- Buprenorphine and Naloxone Buccal Film
- Buprenorphine and Naloxone Sublingual Film
- Buprenorphine/naloxone Oromucosal, Sublingual (Advanced Reading)
Other brands: Suboxone, Zubsolv, Bunavail
Professional resources
- Buprenorphine and Naloxone Sublingual Film (FDA)
- Buprenorphine and Naloxone Sublingual Tablets (FDA)
- Buprenorphine and Naloxone (Wolters Kluwer)
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
